Archive for the 'HIV' Category
More than two decades into the global HIV epidemic, Many HIV positive patients who have access to antiretroviral medications are entering the senior citzen age bracket. A growing number of HIV positive patients will now face a new set of complicated medical problems related to aging. “HIV and Aging” examines the current effects of HIV and HIV medications on the aging patient relating to immune system, neurologic, cardiovascular, pulmonary, renal gastrointestinal, hormonal, bone, joint, and oncological issues.
continue reading »
November 07 2008 | HIV | No Comments »
Hospital disinfectant is highly effective against TB, MRSA, HIV-1 AIDS virus, poliovirus Type 1, hepatitis A and norovirus. Tuberculocidal, virucidal, fungicidal, bactericidal. Eliminates odors and prevents the growth of mold and mildew. Contains no CFC. EPA Registered.
continue reading »
November 07 2008 | HIV | No Comments »
AIDS and HIV Answers
continue reading »
November 05 2008 | HIV | No Comments »
Cleans, disinfects and deodorizes in one easy step. Clinging foam provides longer contact time on vertical surfaces. Kills herpes, HIV-1 AIDS virus, staphylococcus, salmonella, influenza and pseudomonas. EPA Registered.
continue reading »
November 05 2008 | HIV | No Comments »
Forty years ago, the age-old battle against infectious diseases as a major threat to human health was believed close to being won. However, by the late twentieth century, the increase of emerging and reemerging infectious diseases was evident in both low and high income countries. About 30 new infectious diseases have been identified in the last 20 years. Among the ?new? diseases, and most importantly, the Human Immunodeficiency Virus (HIV) epidemic, with 40 million persons infected and 25 million deaths since its first description, presents one of the most significant health, societal and security challenges facing the global community. The interaction of HIV/AIDS with tuberculosis, malaria and bacterial infections have increased HIV-related morbidity and mortality, and in turn, the HIV pandemic has brought about devastating increases in tuberculosis.
Understanding the population impact and the dynamics of infection diseases in the most affected region is critical to efforts to reduce the morbidity and mortality of such infections, and for decisions on where to use limited resources in the fight against infections.
This book aims to contribute to these efforts by offering a demographic and epidemiological perspective on emerging and reemerging infections in sub-Saharan Africa.
continue reading »
November 05 2008 | HIV | No Comments »
« Prev - Next »
